| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01704027 Details | 2014-09-18 Interventional | 2 | 28 | Androgens Prostatic Neopl… Prostate Cancer | termination of the trial after interim analysis. the main criterion could not be reached - | |||
| NCT01363349 NCT01365299 Details | 2014-09-18 Interventional | 2/3 | 269 | Risperidone Schizophrenia Cognitive Effec… | pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020 indicate that the
trial would not meet the pre-specified primary efficacy endpoint. - | |||
| NCT01339026 2010-020219-35 Details | 2014-09-18 Interventional | 4 | 44 | Clopidogrel Prasugrel Hydro… Acute Coronary … Cardiovascular … Syndrome Cardiovascular … | Change in guidelines favouring newer antiplatelet drugs in ACS - | |||
| NCT01031810 Details | 2014-09-18 Interventional | 4 | 13 | Tranylcypromine Depression Depressive Diso… Depressive Diso… Depressive Diso… Major Depressiv… | Needed PET facility closed Early termination leading to small numbers of subjects analyzed | |||
| NCT02242812 Details | 2014-09-17 Interventional | 4 | 24 | Metoprolol Telmisartan Hypertension | - - | |||
| NCT00240162 Details | 2014-09-17 Interventional | 2 | 21 | Vatalanib Multiple Myelom… Neoplasms, Plas… | investigator letter from drug manufacturer stating animal studies showed increased risk of
cancer which was an unknown adverse event In November 2008, it was reported that the drug might have carcinogenic potential in animal models. At that time, the remaining three patients were taken off study. | |||
| NCT01870284 Details | 2014-09-16 Interventional | 3 | 0 | Adalimumab Ixekizumab Spondylarthriti… Spondylitis Spondylitis, An… | Due to unexpected operational issues outside of Lilly's control the study has been closed - | |||
| NCT01164917 Details | 2014-09-16 Interventional | 1 | 16 | Antibodies, Mon… Lupus Erythemat… Lupus Erythemat… Cutaneous Lupus Discoid Lupus Lupus Systemic Lupus … | The 16 subjects enrolled in the study should enable Amgen to adequately assess safety and
tolerabili - | |||
| NCT00784966 Details | 2014-09-16 Interventional | 1/2 | 0 | Etanercept Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes… | University decision. - | |||
| NCT02239835 Details | 2014-09-15 Interventional | 2 | 79 | Ritonavir Saquinavir Tipranavir HIV Infections | - - | |||
| NCT01337427 Details | 2014-09-15 Interventional | 3 | 0 | Interferon beta… Interferon-beta Interferons Multiple Sclero… Multiple Sclero… Sclerosis Relapsing Remit… | The study was not feasible to conduct in the US and abroad. - | |||
| NCT01875107 Details | 2014-09-12 Interventional | 4 | 0 | Insulin Hyperglycemia Hyperglycemia i… | Time constraints of primary investigator. - | |||
| NCT01579578 Details | 2014-09-12 Interventional | 2 | 39 | Paclitaxel Metastatic, Gas… | AstraZeneca sponsored trials of AZD8931 have been halted - | |||
| NCT02154048 Details | 2014-09-11 Interventional | 2 | 5 | Dexamethasone Ropivacaine Surgery, Hand | - - | |||
| NCT02235428 Details | 2014-09-10 Interventional | 4 | 3 | Albuterol Bromides Ipratropium Asthma | - - | |||
| NCT00498433 Details | 2014-09-10 Interventional | 2 | 46 | Aliskiren Amlodipine Hypertension Obesity Obesity, Abdomi… Abdominal Obesi… | Early termination resulted from interim analysis of the ALTITUDE trial - | |||
| NCT00208936 Details | 2014-09-09 Interventional | 2 | - | Fluorouracil Esophageal Dise… Esophageal Neop… | - - | |||
| NCT01841008 Details | 2014-09-05 Interventional | 2/3 | 35 | Tacrolimus Pigmentation Di… Vitiligo | - - | |||
| NCT01786226 Details | 2014-09-05 Interventional | 2/3 | [1 Refs] | 220 | Mifepristone Leiomyoma Myofibroma Uterine Fibroid… | - - | ||
| NCT00177411 Details | 2014-09-05 Interventional | 1 | 0 | Hormones Parathyroid Hor… Parathyroid Hor… Osteoporosis | Protocol design was changed so it no longer fit the description of this study. - |